Devin Whittemore Smith - Net Worth and Insider Trading
Devin Whittemore Smith Net Worth
The estimated net worth of Devin Whittemore Smith is at least $59,077 dollars as of 2025-07-24. Devin Whittemore Smith is the General Counsel of IO Biotech Inc and owns about 16,938 shares of IO Biotech Inc (IOBT) stock worth over $32,690. Devin Whittemore Smith is also the SVP and General Counsel of Yumanity Therapeutics Inc and owns about 13,961 shares of Yumanity Therapeutics Inc (YMTX) stock worth over $26,386. Details can be seen in Devin Whittemore Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Devin Whittemore Smith has not made any transactions after 2024-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Devin Whittemore Smith
Devin Whittemore Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Devin Whittemore Smith owns 4 companies in total, including Minerva Neurosciences Inc (NERV) , Yumanity Therapeutics Inc (YMTX) , and IO Biotech Inc (IOBT) among others .
Click here to see the complete history of Devin Whittemore Smith’s form 4 insider trades.
Insider Ownership Summary of Devin Whittemore Smith
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| NERV | Minerva Neurosciences Inc | 2018-07-23 | SVP and General Counsel |
| YMTX | Yumanity Therapeutics Inc | 2022-12-02 | SVP and General Counsel |
| IOBT | IO Biotech Inc | 2024-12-23 | General Counsel |
 | | 2021-06-14 | SVP and General Counsel |
Devin Whittemore Smith Latest Holdings Summary
Devin Whittemore Smith currently owns a total of 2 stocks. Among these stocks, Devin Whittemore Smith owns 16,938 shares of IO Biotech Inc (IOBT) as of December 23, 2024, with a value of $32,690 and a weighting of 55.34%. Devin Whittemore Smith also owns 13,961 shares of Yumanity Therapeutics Inc (YMTX) as of December 2, 2022, with a value of $26,386 and a weighting of 44.66%.
Latest Holdings of Devin Whittemore Smith
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IOBT | IO Biotech Inc | 2024-12-23 | 16,938 | 1.93 | 32,690 |
| YMTX | Yumanity Therapeutics Inc | 2022-12-02 | 13,961 | 1.89 | 26,386 |
Holding Weightings of Devin Whittemore Smith
Devin Whittemore Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Devin Whittemore Smith has made a total of 1 transactions in IO Biotech Inc (IOBT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IO Biotech Inc is the acquisition of 12,000 shares on December 23, 2024, which cost Devin Whittemore Smith around $9,720.
According to the SEC Form 4 filings, Devin Whittemore Smith has made a total of 2 transactions in Yumanity Therapeutics Inc (YMTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Yumanity Therapeutics Inc is the sale of 3,116 shares on December 2, 2022, which brought Devin Whittemore Smith around $5,266.
Insider Trading History of Devin Whittemore Smith
- 1
Devin Whittemore Smith Trading Performance
GuruFocus tracks the stock performance after each of Devin Whittemore Smith's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Devin Whittemore Smith is 7.9%. GuruFocus also compares Devin Whittemore Smith's trading performance to market benchmark return within the same time period. The performance of stocks bought by Devin Whittemore Smith within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Devin Whittemore Smith's insider trading performs compared to the benchmark.
Performance of Devin Whittemore Smith
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.61 | | | | | |
| Relative Return to S&P 500(%) | -1.81 | | | | | |
Devin Whittemore Smith Ownership Network
Ownership Network List of Devin Whittemore Smith
Ownership Network Relation of Devin Whittemore Smith
Devin Whittemore Smith Owned Company Details
What does Minerva Neurosciences Inc do?
Who are the key executives at Minerva Neurosciences Inc?
Devin Whittemore Smith is the SVP and General Counsel of Minerva Neurosciences Inc. Other key executives at Minerva Neurosciences Inc include 10 percent owner Ag Boehringer , 10 percent owner Boehringer Ingelheim International Gmbh , and EVP and Head of R&D Remy Luthringer .
Minerva Neurosciences Inc (NERV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Minerva Neurosciences Inc (NERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Minerva Neurosciences Inc (NERV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Minerva Neurosciences Inc (NERV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Minerva Neurosciences Inc Insider Transactions
Devin Whittemore Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Devin Whittemore Smith. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Devin Whittemore Smith's mailing address is: Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
